Y. Murawaki et al., MOLECULAR-WEIGHT OF HYALURONATE IN THE SERUM OF PATIENTS WITH CHRONICLIVER-DISEASE, Research communications in molecular pathology and pharmacology, 99(2), 1998, pp. 207-216
Hyaluronate in tissue and lymph is known to be heterogenous and to sho
w a wide range of molecular weights (10(4) to 10(7) Da). Serum hyaluro
nate concentrations are increased under various pathophysiological con
ditions such as liver disease, postgastrectomy, and after the ingestio
n of food. To clarify whether the chromatographic patterns of hyaluron
ate in serum from patients with chronic liver disease are different un
der these conditions, we subjected sera to chromatography using a Seph
acryl S 400 HR column. The chromatograms revealed that the hyaluronate
in serum was eluted as a single peak at the position corresponding to
the molecular weight of blue dextran, the molecular weight being more
than 2 x 10(6) Da. The patterns of the chromatogram were similar amon
g the patients with liver disease and the healthy subject although the
heights of the peaks were different. Ingestion of food and a history
of gastrectomy for gastric cancer did not influence the elution patter
ns of serum hyaluronate. These results indicate that hyaluronate in se
rum has molecular weight of more than 2 x 10(6) Da, and that its eluti
on patterns are not influenced by pathophysiological factors, such as
the severity of liver disease, or history of gastrectomy or by food in
take in patients with chronic liver disease.